Avanos Medical reports Q2 2024 results; filing lacks detailed financials

AVANOS MEDICAL, INC.

2024-Q2 EPS reported $0.02 revenue$337,800,000

Results announced for three and six months ended June 30, 2024.
No specific revenue, EPS, or segment figures available in provided text.
Guidance or outlook not mentioned in the filing excerpt.

item 2.02 item 9.01

AVANOS MEDICAL, INC. filing history →

Source: SEC EDGAR

accession 0001606498-24-000074

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.